(OSCR) Oscar Health - Ratings and Ratios

Oscar Health Inc., listed as OSCR on the NYSE, operates as a health insurance company in the United States, offering plans in the individual and small group markets. The company, founded in 2012 by Mario Schlosser, Joshua Kushner, and Kevin Nazemi, is headquartered in New York. Originally named Mulberry Health Inc., it rebranded to Oscar Health in January 2021. Oscar is known for its consumer-centric approach, leveraging technology to enhance health insurance services.

Central to Oscars offerings is +Oscar, a technology-driven platform designed to assist healthcare providers and payors in transitioning to value-based care. This platform provides tools for analytics, care management, and patient engagement, aiming to improve care outcomes while reducing costs. Additionally, Oscar offers reinsurance products, which are crucial for managing risk and stabilizing insurance markets.

With a market capitalization of approximately $3.27 billion, Oscars financial metrics are notable. The companys P/E ratio stands at 130.60, indicating a high valuation relative to earnings, which may reflect market expectations for future growth. The forward P/E ratio of 18.38 suggests anticipated earnings growth. The price-to-sales ratio is 0.40, indicating significant revenue generation relative to market cap. Oscars strategic use of technology positions it as an innovator in a traditionally slow-moving industry.

Oscar has expanded its services beyond individual plans to include small businesses and Medicare Advantage, showcasing its growth and diversification. For more information, visit their website at https://www.hioscar.com.